Atlas Trials

Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia

Clinical trial NCT00004857 · COMPLETED

Trial details

NCT number
NCT00004857
Sponsor
Alliance for Clinical Trials in Oncology
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Leukemia
Start date
2000-01-01
Primary completion
2003-03-01
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.